Home Cart 0 Sign in  
X

[ CAS No. 105603-49-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 105603-49-4
Chemical Structure| 105603-49-4
Chemical Structure| 105603-49-4
Structure of 105603-49-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 105603-49-4 ]

Related Doc. of [ 105603-49-4 ]

Alternatived Products of [ 105603-49-4 ]

Product Details of [ 105603-49-4 ]

CAS No. :105603-49-4 MDL No. :MFCD01412199
Formula : C8H7BrO4 Boiling Point : -
Linear Structure Formula :- InChI Key :DADZQRYTHXRMPM-UHFFFAOYSA-N
M.W : 247.04 Pubchem ID :53429428
Synonyms :

Calculated chemistry of [ 105603-49-4 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 49.47
TPSA : 66.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.06 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.24
Log Po/w (XLOGP3) : 2.46
Log Po/w (WLOGP) : 1.65
Log Po/w (MLOGP) : 1.48
Log Po/w (SILICOS-IT) : 1.43
Consensus Log Po/w : 1.85

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.13
Solubility : 0.183 mg/ml ; 0.00074 mol/l
Class : Soluble
Log S (Ali) : -3.51
Solubility : 0.0771 mg/ml ; 0.000312 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.18
Solubility : 1.62 mg/ml ; 0.00658 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.88

Safety of [ 105603-49-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 105603-49-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 105603-49-4 ]
  • Downstream synthetic route of [ 105603-49-4 ]

[ 105603-49-4 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 67-56-1 ]
  • [ 72517-15-8 ]
  • [ 105603-49-4 ]
YieldReaction ConditionsOperation in experiment
78%
Stage #1: at 20℃; for 0.5 h;
Stage #2: at 20℃; for 9 h; Heating / reflux
A mixture of thionyl chloride (0.35 mL, 4.8 mmol) and methanol (5.4 mL) was stirred at room temperature for 30 min then treated with part B compound (600 mg, 2.57 mmol). The reaction mixture was stirred at room temperature for 2.0 hr. refluxed for 7.0 hr, cooled and concentrated to a brown solid. Purification by column chromatography (2.5.x.25 cm column, 1:4 EtOAc/hexane, then 1:1 EtOAc) gave the title compound (500 mg, 78percent).
12.5 g at 0℃; Reflux; Inert atmosphere SOCl2(13.1 mL, 180.9 mmol) was added dropwise into a solution of the compound (17-1) (14.1 g, 60.3 mmol) in 27 MeOH (200 mL) at 0°C in a nitrogen atmosphere. A resulting mixture was stirred at reflux overnight. After a reaction was completed, a volatile solvent was evaporated under reduced pressure. A resulting residue was purified by means of a silica gel column chromatography, so as to obtain the 106 title compound (17-2) (12.5 g, 50.6 mmol, 84percent). (0144) 1H NMR (400 MHz, CDCl3); δ 10.85 (s, 1H), 7.51 (s, 1H), 7.23 (s, 1H), 5.69 (s, 1H), 3.96 (s, 3H)
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 19, p. 2279 - 2280
[2] Patent: US2003/225091, 2003, A1, . Location in patent: Page 63
[3] Patent: US2005/137162, 2005, A1, . Location in patent: Page/Page column 6
[4] Chemistry - A European Journal, 2011, vol. 17, # 23, p. 6369 - 6381
[5] Patent: EP3404033, 2018, A1, . Location in patent: Paragraph 0143-0144
  • 2
  • [ 303-38-8 ]
  • [ 105603-49-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 19, p. 2279 - 2280
[2] Chemistry - A European Journal, 2011, vol. 17, # 23, p. 6369 - 6381
[3] Patent: EP3404033, 2018, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 105603-49-4 ]

Aryls

Chemical Structure| 72517-23-8

[ 72517-23-8 ]

5-Bromo-2,3-dimethoxybenzoic acid

Similarity: 0.93

Chemical Structure| 22717-56-2

[ 22717-56-2 ]

Methyl 4-bromo-2-hydroxybenzoate

Similarity: 0.93

Chemical Structure| 1312609-83-8

[ 1312609-83-8 ]

Ethyl 4-bromo-2,3-dihydroxybenzoate

Similarity: 0.92

Chemical Structure| 39503-58-7

[ 39503-58-7 ]

Methyl 5-bromo-2-methoxy-4-methylbenzoate

Similarity: 0.92

Chemical Structure| 90326-61-7

[ 90326-61-7 ]

5-Bromo-2-methoxy-4-methylbenzoic acid

Similarity: 0.90

Bromides

Chemical Structure| 72517-23-8

[ 72517-23-8 ]

5-Bromo-2,3-dimethoxybenzoic acid

Similarity: 0.93

Chemical Structure| 22717-56-2

[ 22717-56-2 ]

Methyl 4-bromo-2-hydroxybenzoate

Similarity: 0.93

Chemical Structure| 1312609-83-8

[ 1312609-83-8 ]

Ethyl 4-bromo-2,3-dihydroxybenzoate

Similarity: 0.92

Chemical Structure| 39503-58-7

[ 39503-58-7 ]

Methyl 5-bromo-2-methoxy-4-methylbenzoate

Similarity: 0.92

Chemical Structure| 90326-61-7

[ 90326-61-7 ]

5-Bromo-2-methoxy-4-methylbenzoic acid

Similarity: 0.90

Esters

Chemical Structure| 22717-56-2

[ 22717-56-2 ]

Methyl 4-bromo-2-hydroxybenzoate

Similarity: 0.93

Chemical Structure| 1312609-83-8

[ 1312609-83-8 ]

Ethyl 4-bromo-2,3-dihydroxybenzoate

Similarity: 0.92

Chemical Structure| 39503-58-7

[ 39503-58-7 ]

Methyl 5-bromo-2-methoxy-4-methylbenzoate

Similarity: 0.92

Chemical Structure| 28165-45-9

[ 28165-45-9 ]

Methyl 3-bromo-2-hydroxybenzoate

Similarity: 0.90

Chemical Structure| 39503-52-1

[ 39503-52-1 ]

Methyl 5-bromo-2-hydroxy-4-methoxybenzoate

Similarity: 0.87